JP2024543372A5 - - Google Patents
Info
- Publication number
- JP2024543372A5 JP2024543372A5 JP2024527320A JP2024527320A JP2024543372A5 JP 2024543372 A5 JP2024543372 A5 JP 2024543372A5 JP 2024527320 A JP2024527320 A JP 2024527320A JP 2024527320 A JP2024527320 A JP 2024527320A JP 2024543372 A5 JP2024543372 A5 JP 2024543372A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- substituted
- independently
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163279270P | 2021-11-15 | 2021-11-15 | |
| US63/279,270 | 2021-11-15 | ||
| PCT/US2022/079790 WO2023086979A1 (en) | 2021-11-15 | 2022-11-14 | Staggered triple lipid-modified nucleic acid compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543372A JP2024543372A (ja) | 2024-11-21 |
| JP2024543372A5 true JP2024543372A5 (https=) | 2025-11-27 |
Family
ID=86336682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527320A Pending JP2024543372A (ja) | 2021-11-15 | 2022-11-14 | ねじれ形３種脂質修飾核酸化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250027082A1 (https=) |
| EP (1) | EP4433064A1 (https=) |
| JP (1) | JP2024543372A (https=) |
| KR (1) | KR20240103016A (https=) |
| CN (1) | CN118215484A (https=) |
| AU (1) | AU2022387688A1 (https=) |
| CA (1) | CA3235447A1 (https=) |
| IL (1) | IL312217A (https=) |
| MX (1) | MX2024005742A (https=) |
| WO (1) | WO2023086979A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120247995A (zh) * | 2018-05-30 | 2025-07-04 | 诺华股份有限公司 | 脂质修饰的核酸化合物和方法 |
| CA3166370A1 (en) * | 2019-11-27 | 2021-06-03 | Dtx Pharma, Inc. | Compounds and methods for the treatment of duchenne muscular dystrophy |
-
2022
- 2022-11-14 JP JP2024527320A patent/JP2024543372A/ja active Pending
- 2022-11-14 IL IL312217A patent/IL312217A/en unknown
- 2022-11-14 CN CN202280074512.5A patent/CN118215484A/zh active Pending
- 2022-11-14 CA CA3235447A patent/CA3235447A1/en active Pending
- 2022-11-14 US US18/708,787 patent/US20250027082A1/en active Pending
- 2022-11-14 KR KR1020247019235A patent/KR20240103016A/ko active Pending
- 2022-11-14 WO PCT/US2022/079790 patent/WO2023086979A1/en not_active Ceased
- 2022-11-14 MX MX2024005742A patent/MX2024005742A/es unknown
- 2022-11-14 EP EP22893903.9A patent/EP4433064A1/en active Pending
- 2022-11-14 AU AU2022387688A patent/AU2022387688A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6066447A (en) | Modified oligonucleotides | |
| US7053199B2 (en) | Nucleoside analogs and oligonucleotide derivatives containing these analogs | |
| KR100571299B1 (ko) | 펜토피라노실 뉴클레오시드 및 이의 제조방법 | |
| JP4461278B2 (ja) | 新規な塩基対形成スキームの使用による非特異的ハイブリダイゼーションの減少 | |
| JP7748500B2 (ja) | トリループを含む二本鎖核酸インヒビター分子 | |
| WO2021037205A1 (zh) | 化合物和药物缀合物及其制备方法和用途 | |
| JP2005519035A5 (https=) | ||
| Sproat et al. | New synthetic routes to synthons suitable for 2′-O-allyloligoribonucleotide assembly | |
| JP2024079716A5 (https=) | ||
| JP2023503644A5 (https=) | ||
| JP2019141097A5 (https=) | ||
| CA2628883C (en) | Novel 3'-modified oligonucleotide derivatives | |
| JP2022501059A5 (https=) | ||
| PT98931B (pt) | Processo para a ligacao de nucleosidos com uma ponte siloxano | |
| JP2022552249A5 (https=) | ||
| JP2022533419A5 (https=) | ||
| US5936077A (en) | Solid phase synthesis of oligonucleotides | |
| JP2024543372A5 (https=) | ||
| JP2023535730A5 (https=) | ||
| JP2022526267A5 (https=) | ||
| EP0906329B1 (en) | 2'-substituted nucleosides and oligonucleotide derivatives | |
| JP2024544975A5 (https=) | ||
| JP2024505226A5 (https=) | ||
| JP2025511183A5 (https=) | ||
| Benseler et al. | Synthesis of suitably-protected phosphoramidites of 2′-fluoro-2′-deoxyguanosine and 2′-amino-2′-deoxyguanosine for incorporation into oligoribonucleotides |